The 2017 European Leukemianet Genetic Risk Classification Performs Poorly in Older Patients with Acute Myeloid Leukemia (AML) and Should be Refined to Identify Patients Requiring Additional or Alternative Treatment
Year: 2019
Type: conference-abstract
Source: Blood
Authors: Ann-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, Dimitrios Papaioannou, Christopher J. Walker, James S. Blachly, Sophia E. Maharry, Andrew J. Carroll, Richard M. Stone, Bayard L Powell, Albert de la Chapelle, Eunice S. Wang, Jonathan E. Kolitz, John C. Byrd, Clara D. Bloomfield
Institutions: The Ohio State University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, University of Alabama at Birmingham, Harvard University, Dana-Farber Cancer Institute, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University Health Sciences, Roswell Park Comprehensive Cancer Center, Northwell Health, Hofstra University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2984513470